维普期刊资源整合服务平台（V6.5）

98篇 您的检索式：作者名="Labianca G"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Modilated 5 - fluorouracil (5 - FU) regimens in advanced colorectal cancer: a critical review of comparative studies 显示文摘	LABIANCA R PESSi A FACENDOLA G	1996	Eur J Cancer1996，32，15：	1
2	A multilevel model of group social capital显示文摘	Oh H Labianca G Chung M H	2006	Academy of Management Review2006，31，3：	1
3	Cardiac toxicity of 5-flurouracil: A study of 1083 patients显示文摘	Labianca R Beretta G Clerici M et aI	1982	Tumori1982，68，6：	1
4	Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer:the GIP-1 study显示文摘	Colucci G Labianca R Di Costanzo F		0，，10：	1
5	Randomized phase IH trim of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pan- creatic cancer: the GIP-I study显示文摘	Colucci G Labianca R Di Costanzo F	2010	J Clin Oncol2010，28，10：	1
6	The role of instru- mental and expressive social ties in employees' perceptions of organiza- tional justice 显示文摘	UMPHRESS E E LABIANCA G BRASS D J	2003	Organization Science2003，14，6：	1
7	A multilevel model of group social capital显示文摘	Oh H Labianca G Chung M H	2006	Academy of Management Review2006，31，3：	1
8	Group social capital and group effectiveness: the role of informal socializing ties 显示文摘	Oh H Chung M H Labianca G	2004	Academy of Management Journal2004，47，6：	1
9	Network Analysis in the Social Sciences显示文摘	Borgatti S.P Mehra A Brass D.J Labianca G		0，，：	1
10	Randomized phase ]II trial of gemcitabine plus cisplatin compared with single - agent gemeitabine as first - line treatment of pa- tients with advanced pancreatic cancer: the GIP - 1 study 显示文摘	Colucei G Labianca R Di Costanzo F	2010	J Clin 0ncol2010，28，10：	1
11	A multilevel model of group social capital显示文摘	Oh H Labianca G Chung M	2006	Academy of Management Re- view2006，31，3：	1
12	Pri mary colon cancer: ESMO clinical practice guidelines for diagnosis, adjuvant treatment and follow-up 显示文摘	LABIANCA R NORDLINGER B BERETTA G D	2010	Ann Oncol2010，21，5：	1
13	A multilevel model of group social capital显示文摘	Oh H Labianca G Chung M H	2006	Academy of Management Re- view2006，31，3：	1
14	Group social capital and group effectiveness: The role of informal sociali- zing ties显示文摘	Oh H Chung M H Labianca G	2004	Academy of Management Journal2004，47，6：	1
15	Randomized phase Ⅲtrial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer:the GIP-1 study显示文摘	Colucci G Labianca R Di Costanzo F		0，，10：	1
16	Treatment of colorectal cancer current guidelines and future prospects for drug therapy 显示文摘	Labianca R Pessitt MA Zamparelli G	1997	Drugs1997，53，4：	1
17	Medical treatment of hepatocellular carcinoma显示文摘	Luporini G Labianca R Pancera G	1993	J Sarg Oncol1993，3，：	1
18	Efficacy of adjuvant fluorouracil and folinic acid in colon cancer显示文摘	Labianca R Masoni S Pancera G	1995	Lancet1995，345，8955：	1
19	A randomized trial of gemcitabine(G)versus G plus cisplatin in chemotherapy-naive advanced pancreatic adenocarcinoma:The GIP-1(Gruppo Italiano Pancreas-GOIM/GISCAD/GOIRC)study显示文摘	Colucci G Labianca R Di Costanzo F	2009	J Clin Oncol2009，27，：	1
20	Chemotherapy-as- sociated thromboembolic risk in cancer out-patients and effect of nadroparin thrombo-pmphylaxis: results of a retrospective analysis of the protect study显示文摘	BARNI S LABIANCA R AGNELLI G	2011	J Transl Med2011，9，1：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示